Hidradenitis Suppurativa Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Hidradenitis Suppurativa Industry Compare Between 2025 And 2029?

The hidradenitis suppurativa market has experienced robust expansion in recent years. Projections indicate its value will rise from $1.16 billion in 2024 to $1.24 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this historical growth include heightened awareness regarding diagnosis, the limited array of available treatment options, significant advancements within dermatology, an increase in disease prevalence, and various patient advocacy efforts.

The hidradenitis suppurativa market size is anticipated to undergo significant growth over the upcoming years. It is predicted to expand to $1.63 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.9%. This expansion during the forecast period is primarily driven by the development of biologic therapies, the implementation of precision medicine approaches, the broadening of clinical trials, global initiatives and funding, and supportive healthcare policy. Prominent trends expected in the forecast period include advanced immunomodulatory therapies, the adoption of telemedicine and remote monitoring, a focus on patient-centric care, the use of minimally invasive surgical interventions, and personalized lifestyle recommendations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12599&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Hidradenitis Suppurativa Industry?

The increasing prevalence of various skin conditions is projected to drive the expansion of the hidradenitis suppurativa market. These conditions encompass a broad spectrum of dermatological issues, including those stemming from bacterial, viral, and fungal infections, allergic reactions, skin malignancies, and parasitic infestations. Hidradenitis suppurativa (HS) itself, a chronic and severe skin disorder, is stimulating the development of new products and services for its management, propelled by greater public awareness, more accurate diagnostic tools, an expanding patient population, and advancements in research. For example, in January 2024, the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, reported an anticipated 108,270 cases of skin cancer, representing a 3.2% increase from the 104,930 cases documented in 2023. Thus, the escalating incidence of skin diseases serves as a significant impetus for the growth of the hidradenitis suppurativa market.

How Is The Hidradenitis Suppurativa Market Classified Into Different Segments?

The hidradenitis suppurativamarket covered in this report is segmented –

1) By Skin Condition: Folliculitis; Pimples; Boils; Deep-Acne

2) By Product: Tablet; Intravenous (IV) Injection

3) By Route Of Administration: Oral; Parenteral

4) By Treatment: Medications; Surgery; Photodynamic Therapy (PDT); Laser Treatment; Other Treatments

5) By End User: Hospital; Specialty Clinic; Homecare; Other End Users

Subsegments:

1) By Folliculitis: Acute Folliculitis; Chronic Folliculitis

2) By Pimples: Non-Inflammatory Pimples; Inflammatory Pimples

3) By Boils: Single Boil; Recurrent Boils

4) By Deep-Acne: Cysts; Nodules

Which Market Trends Are Creating New Opportunities In The Hidradenitis Suppurativa Industry?

The increasing application of biologics represents a key trend gaining momentum in the hidradenitis suppurativa market. Major companies operating in the hidradenitis suppurativa market are committing resources to research and development, which has led to an approved biologic therapy for hidradenitis suppurativa and sustained their market standing. For example, in June 2023, the European regulatory authority provided approval to Novartis AG, a Switzerland-based pharmaceutical company, for Cosentyx for hidradenitis suppurativa. Cosentyx is distinctive as the first and only fully human biologic that specifically inhibits interleukin-17A, a crucial cytokine associated with hidradenitis suppurative disease. Cosentyx is a recognized medication that has undergone clinical investigation for over 14 years.

Who Are The Top Performing Companies In The Hidradenitis Suppurativa Market In Recent Years?

Major companies operating in the hidradenitis suppurativa market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Co Ltd., UCB S.A., Leo Pharma A/S, Almirall S.A., Acelyrin Inc., AnaptysBio Inc., Arcutis Biotherapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Yamo Pharmaceuticals, Bayer AG, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Chemocentryx, Priovant Therapeutics, Aristea Therapeutics, Samsung Bioepis, Organon, Union Therapeutics, Revance Therapeutics, Dermavant Sciences, Dermira Inc., MedImmune LLC, Taro Pharmaceutical Industries Ltd., Immunic Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report

How Is Hidradenitis Suppurativa Market Demand Varying Across Different Regions?

North America was the largest region in the hidradenitis suppurativa market in 2024. The regions covered in the hidradenitis suppurativa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Hidradenitis Suppurativa Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12599&type=smp

Browse Through More Reports Similar to the Global Hidradenitis Suppurativa Market 2025, By The Business Research Company

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

Support Activities For Printing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/support-activities-for-printing-global-market-report

Printing And Related Support Activities Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/printing-and-related-support-activities-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795